NCT03074097View on ClinicalTrials.gov

Rectus Sheath Block: Postoperative Analgesia and Proinflammatory Cytokines

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 5, 2015

Primary Completion Date

February 1, 2016

Study Completion Date

April 28, 2016

Conditions
Postoperative Pain
Interventions
DRUG

Bupivacaine 0.25%

Each patient received bilateral single shot ultrasound guided rectus sheath block under complete aseptic condition in a dose of 30 ml of bupivacaine 0.25% in each side immediately after induction of general anaesthesia

Trial Locations (1)

Unknown

Assiut university faculty of medicine, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03074097 - Rectus Sheath Block: Postoperative Analgesia and Proinflammatory Cytokines | Biotech Hunter | Biotech Hunter